BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-21 Cr | ₹-25 Cr | ₹-24 Cr | ₹-21 Cr | ₹-6.30 Cr |
What is the latest Cash Flow from Financing Activities ratio of BLISS GVS PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-21 Cr |
Mar2023 | ₹-25 Cr |
Mar2022 | ₹-24 Cr |
Mar2021 | ₹-21 Cr |
Mar2020 | ₹-6.30 Cr |
How is Cash Flow from Financing Activities of BLISS GVS PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-21 Cr | Negative | |
Mar2023 | ₹-25 Cr | Negative | |
Mar2022 | ₹-24 Cr | Negative | |
Mar2021 | ₹-21 Cr | Negative | |
Mar2020 | ₹-6.30 Cr | - |
Compare Cash Flow from Financing Activities of peers of BLISS GVS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BLISS GVS PHARMA | ₹1,697.5 Cr | -0.2% | 12.5% | 32% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹446,684.0 Cr | 2.9% | 6.4% | 48.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,935.0 Cr | 0.5% | -2.1% | 59.2% | Stock Analytics | |
CIPLA | ₹121,639.0 Cr | 2.3% | 1% | 20.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹115,931.0 Cr | 3.5% | 15.7% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,876.4 Cr | -0.1% | 2.3% | 41.1% | Stock Analytics |
BLISS GVS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BLISS GVS PHARMA | -0.2% |
12.5% |
32% |
SENSEX | -0.7% |
-1.6% |
11.1% |
You may also like the below Video Courses